| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |